U.S. drugmaker Eli Lilly on Monday said it has appointed insider Lucas Montarce as its new chief financial officer, effective immediately, months after...
- U.S. drugmaker Eli Lilly on Monday said it has appointed insider Lucas Montarce as its new chief financial officer , effective immediately, months after former CFO Anat Ashkenazi stepped down to join Google parent Alphabet.
Shares of the company were flat in afternoon trading. The Indianapolis-based drugmaker is already the world's most valuable healthcare company, primarily due to the high demand for its weight-loss treatments. "Lucas was very much groomed probably to be the next CFO," Wagner said, pointing to Montarce's experience being similar to Ashkenazi's within the company.
A City accounting giant has been accused of “actively participat in the suppression of free press” in Hong Kong by pro-democracy campaigners.MIAMI GARDENS, Fla. — The president of South Florida's police union said Miami Dolphins player Tyreek Hill was handcuffed and placed face down on the ground during a traffic stop because he was not “immediately cooperative” with officers, while Hill said he was respectful throughout the interaction.
Anat Ashkenazi Chief Financial Officer Lucas Montarce Research Laboratories Dave Wagner Finance Chief
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly appoints insider Lucas Montarce as finance chief amid rising investments to boost capacityThe executive change comes months after former CFO Anat Ashkenazi stepped down to join Google parent Alphabet
Read more »
Bronfman drops Paramount bid, Eli Lilly lowers weightloss drug price: Yahoo FinanceThe saga for Paramount Global (PARA) seems to be nearing an end. Edgar Bronfman Jr. has abandoned his bid for the studio, clearing the path for Skydance...
Read more »
Eli Lilly has 'a good story': Deutsche Bank analyst on upgradeDeutsche Bank is out with a bullish call on Eli Lilly (LLY), raising its rating on the pharma stock from Hold to Buy and lifting its price target by $300 to ...
Read more »
Eli Lilly Selling $5 Billion of Bonds to Fund Morphic Deal(Bloomberg) -- Eli Lilly & Co. is selling $5 billion of bonds on Monday to help fund its $3.2 billion acquisition of gut-drug maker Morphic Holding Inc...
Read more »
What Eli Lilly, Novo Nordisk earnings reveal about the future of GLP-1 salesGLP-1s continue to fuel investor interest in market competition, as companies prepare to differentiate themselves in the coming year.
Read more »
Tech market values fall on AI costs and recession fears; Eli Lilly, Berkshire gainLast month, Alphabet Inc's lost 4.7% of its market value as a slowdown in YouTube's advertising sales fuelled concerns about its earnings. Amazon.com Inc's ...
Read more »